(Q38347034)

2 September 2017

title

Human endometrial leukemia inhibitor factor (LIF) secretion and its relationship to sonographic endometrial appearance (English)

1 reference

2 September 2017

Hambartsoumian E

1

1 reference

2 September 2017

publication date

1 April 1997

1 reference

American Journal of Reproductive Immunology

2 September 2017

published in

1 reference

2 September 2017

volume

37

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

320-325

1 reference

The leukemia inhibitory factor (LIF)

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Leukemia inhibitory factor: a biological perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Expression of leukemia inhibitory factor in human endometrium and placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00237.X

10.1111/J.1600-0897.1997.TB00237.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference